This disclosure is directed to compositions and methods for utilizing the boundaries of the C-terminal domains of Nucleoprotein from Zaire Ebola virus as highly stable recombinant protein antigens to generate antibodies for diagnosis and treatment of Ebola virus infection.
Details
Title
RECOMBINANT ANTIBODIES THAT RECONGNIZE THE C-TERMINAL DOMAINS OF EBOLA VIRUS NUCLEOPROTEIN
Inventors
Derewenda, Zygmunt S. : University of Virginia Engel, Daniel A. : University of Virginia Kossiakoff, Anthony : University of Chicago Davydova, Elena K. : University of Chicago Jaskolowski, Mateusz : University of Chicago
Applicants
University of Virginia Patent Foundation University of Chicago
